This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Vedic Lifesciences Eyes Malaysian Expansion

REDWOOD SHORES, Calif.—Vedic Lifesciences, a contract research organization (CRO) with offices in India and California, has begun its expansion into Malaysia, engaging key opinion leaders (KOLs) in therapeutic areas including endocrinology, cardiology, orthopedics and urology, general/family physicians and many medical experts from the industry.  The end goal is to develop a ready-to-start, audited investigators’ database in Malaysia for human clinical studies on nutraceutical products, which will help Vedic offer its clients multinational clinical studies.

The company said Southeast Asia has emerged as a hub for clinical studies, thanks to a growing pool of physicians trained in Good Clinical Practices (GCPs) and access to a vast pool of genetically, culturally and socio-economically diverse patient population. In recent years, Malaysia has experienced solid growth in its nutraceutical market and clinical studies supporting nutraceutical products, according to Vedic, which placed the 2010 Malaysian nutraceutical market at approximately  $165 million USD with a compounded annual growth rate (CAGR)of approximately 15 percent.  The company further noted 13 of 235 Malaysian-based clinical trials registered on were on nutraceutical products. 

Jayesh Chaudhary, Vedic Lifesciences CEO, said the strategic move was prompted by the geographical proximity of Malaysia to India, and his company's past experience of working with Malaysian nutraceutical clients. "As increasing number of companies are keen on having local sites for the study, Vedic decided to tap resources and network in Malaysia for companies which are keen on conducting trials in Malaysia or entering the Malaysian market," he explained. "With over a decade of experience, we feel fully confident of delivering our best to clients who seek to conduct studies in this country."  He added Vedic also plans to open sites in other South East Asian countries including China and Singapore by the 3rd financial quarter of this year.  "We are networking with potential nutraceutical, dietary supplement and natural product clients in these regions."


comments powered by Disqus